↓ Skip to main content

Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer

Overview of attention for article published in Advances in Therapy, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
2 X users
patent
10 patents

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
25 Mendeley